BEAM
Price
$33.99
Change
+$0.45 (+1.34%)
Updated
Feb 23, 6:59 PM EST
3 days until earnings call
PGEN
Price
$1.46
Change
+$0.02 (+1.39%)
Updated
Feb 23, 6:59 PM EST
5 days until earnings call
Ad is loading...

Analysis and predictions BEAM vs PGEN

Header iconBEAM vs PGEN Comparison
Open Charts BEAM vs PGENBanner chart's image
Beam Therapeutics
Price$33.99
Change+$0.45 (+1.34%)
Volume$561.87K
CapitalizationN/A
Precigen
Price$1.46
Change+$0.02 (+1.39%)
Volume$524.13K
CapitalizationN/A
View a ticker or compare two or three
BEAM vs PGEN Comparison Chart

Loading...

BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PGENDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BEAM vs. PGEN commentary
Feb 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and PGEN is a Buy.

COMPARISON
Comparison
Feb 24, 2024
Stock price -- (BEAM: $34.03 vs. PGEN: $1.46)
Brand notoriety: BEAM and PGEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 71% vs. PGEN: 92%
Market capitalization -- BEAM: $2.77B vs. PGEN: $363.42M
BEAM [@Biotechnology] is valued at $2.77B. PGEN’s [@Biotechnology] market capitalization is $363.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $552.93B to $0. The average market capitalization across the [@Biotechnology] industry is $2.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whilePGEN’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • PGEN’s FA Score: 0 green, 5 red.
According to our system of comparison, both BEAM and PGEN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 7 TA indicator(s) are bullish while PGEN’s TA Score has 7 bullish TA indicator(s).

  • BEAM’s TA Score: 7 bullish, 4 bearish.
  • PGEN’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, PGEN is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +3.43% price change this week, while PGEN (@Biotechnology) price change was +2.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.03%. For the same industry, the average monthly price growth was +18.51%, and the average quarterly price growth was +38.88%.

Reported Earning Dates

BEAM is expected to report earnings on May 07, 2024.

PGEN is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (+2.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BEAM with price predictions.
OPEN
A.I.dvisor published
a Summary for PGEN with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BEAM($2.77B) has a higher market cap than PGEN($363M). BEAM YTD gains are higher at: 25.018 vs. PGEN (8.955). PGEN has higher annual earnings (EBITDA): -77.27M vs. BEAM (-379.73M). BEAM has more cash in the bank: 1.02B vs. PGEN (73.8M). PGEN has less debt than BEAM: PGEN (7.39M) vs BEAM (173M). BEAM has higher revenues than PGEN: BEAM (81.6M) vs PGEN (6.76M).
BEAMPGENBEAM / PGEN
Capitalization2.77B363M764%
EBITDA-379.73M-77.27M491%
Gain YTD25.0188.955279%
P/E RatioN/AN/A-
Revenue81.6M6.76M1,207%
Total Cash1.02B73.8M1,375%
Total Debt173M7.39M2,340%
TECHNICAL ANALYSIS
Technical Analysis
BEAMPGEN
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 20 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PGENDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WHGOX11.490.04
+0.35%
Westwood Income Opportunity Ultra
ACVUX8.280.02
+0.24%
American Century International Value I
TRSCX27.860.02
+0.07%
TIAA-CREF Social Choice Eq Retire
DTLVX20.77N/A
N/A
Wilshire Large Company Value Invmt
NSFKX12.35N/A
N/A
Natixis Sustainable Future 2050 N